| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 5 297-301, Copyright © 1997 by American Association for Cancer Research
ARTICLES |
LM Marshall, DJ Hunter, JL Connolly, SJ Schnitt, C Byrne, SJ London and GA Colditz
Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Epidemiological studies using the histological classification of Page for benign breast disease consistently demonstrate a positive association between atypical hyperplasia and the subsequent development of breast cancer. However, atypical hyperplasia is of either lobular or ductal types, and breast cancer risk in relation to type of atypical hyperplasia has not been studied extensively. Thus, we investigated prospectively the risk of breast cancer associated with histological subtypes of benign proliferative breast disease, including the types of atypical hyperplasia, among participants in the Nurses' Health Study who had biopsy-confirmed benign breast disease. Women who subsequently developed breast cancer were matched by year of birth and year of biopsy to participants who were free from breast cancer. Benign biopsy slides were classified according to the criteria of Page. Odds ratios (ORs) of breast cancer and 95% confidence intervals (CIs), adjusted for the matching variables and other breast cancer risk factors, were computed using unconditional logistic regression with benign nonproliferative breast disease as the referent group. Atypical ductal hyperplasia (OR = 2.4; 95% CI, 1.3-4.5) or atypical lobular hyperplasia (OR = 5.3; 95% CI, 2.7-10.4) in a prior biopsy were associated with increased breast cancer risk. Atypical lobular hyperplasia was more strongly associated with the risk of premenopausal breast cancer (OR = 9.6; 95% CI, 3.3-27.8) than with the risk of postmenopausal breast cancer (OR = 3.7; 95% CI, 1.3-10.2). The association of atypical ductal hyperplasia and breast cancer risk varied little by menopausal status. The magnitude of breast cancer risk seems to vary according to the type of atypical hyperplasia present at biopsy.
This article has been cited by other articles:
![]() |
M. J. Worsham, U. Raju, M. Lu, A. Kapke, J. Cheng, and S. R. Wolman Multiplicity of Benign Breast Lesions Is a Risk Factor for Progression to Breast Cancer Clin. Cancer Res., September 15, 2007; 13(18): 5474 - 5479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Degnim, D. W. Visscher, H. K. Berman, M. H. Frost, T. A. Sellers, R. A. Vierkant, S. D. Maloney, V. S. Pankratz, P. C. de Groen, W. L. Lingle, et al. Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study J. Clin. Oncol., July 1, 2007; 25(19): 2671 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Ashbeck, R. D. Rosenberg, P. M. Stauber, and C. R. Key Benign Breast Biopsy Diagnosis and Subsequent Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Mahoney, T. M. Robinson-Smith, and E. A. Shaughnessy Lobular Neoplasia at 11-Gauge Vacuum-Assisted Stereotactic Biopsy: Correlation with Surgical Excisional Biopsy and Mammographic Follow-Up Am. J. Roentgenol., October 1, 2006; 187(4): 949 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guray and A. A. Sahin Benign breast diseases: classification, diagnosis, and management. Oncologist, May 1, 2006; 11(5): 435 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Baker, G. P. Beehler, A. C. Sawant, V. Jayaprakash, S. E. McCann, and K. B. Moysich Consumption of Coffee, but Not Black Tea, Is Associated with Decreased Risk of Premenopausal Breast Cancer J. Nutr., January 1, 2006; 136(1): 166 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Page and J. F. Simpson What Is Atypical Lobular Hyperplasia and What Does It Mean for the Patient? J. Clin. Oncol., August 20, 2005; 23(24): 5432 - 5433. [Full Text] [PDF] |
||||
![]() |
P. J. Chuba, M. R. Hamre, J. Yap, R. K. Severson, D. Lucas, F. Shamsa, and A. Aref Bilateral Risk for Subsequent Breast Cancer After Lobular Carcinoma-In-Situ: Analysis of Surveillance, Epidemiology, and End Results Data J. Clin. Oncol., August 20, 2005; 23(24): 5534 - 5541. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Hartmann, T. A. Sellers, M. H. Frost, W. L. Lingle, A. C. Degnim, K. Ghosh, R. A. Vierkant, S. D. Maloney, V. S. Pankratz, D. W. Hillman, et al. Benign Breast Disease and the Risk of Breast Cancer N. Engl. J. Med., July 21, 2005; 353(3): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tan-Chiu, J. Wang, J. P. Costantino, S. Paik, C. Butch, D. L. Wickerham, B. Fisher, and N. Wolmark Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer J Natl Cancer Inst, February 19, 2003; 95(4): 302 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Byrne, P. M. Webb, T. W. Jacobs, G. Peiro, S. J. Schnitt, J. L. Connolly, W. C. Willett, and G. A. Colditz Alcohol Consumption and Incidence of Benign Breast Disease Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1369 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Thomas, R. A. Carter, W. H. Bush Jr., R. M. Ray, J. L. Stanford, C. D. Lehman, J. R. Daling, K. Malone, and S. Davis Risk of Subsequent Breast Cancer in Relation to Characteristics of Screening Mammograms from Women Less Than 50 Years of Age Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Shaaban, J. P. Sloane, C. R. West, and C. S. Foster Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-{alpha} and Ki-67 Expression Am. J. Pathol., February 1, 2002; 160(2): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Daly and E. A. Ross Predicting Breast Cancer: the Search for a Model J Natl Cancer Inst, August 2, 2000; 92(15): 1196 - 1197. [Full Text] [PDF] |
||||
![]() |
C. J. Fabian, B. F. Kimler, C. M. Zalles, J. R. Klemp, S. Kamel, S. Zeiger, and M. S. Mayo Short-Term Breast Cancer Prediction by Random Periareolar Fine-Needle Aspiration Cytology and the Gail Risk Model J Natl Cancer Inst, August 2, 2000; 92(15): 1217 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gobbi, W. D. Dupont, J. F. Simpson, W.D. Plummer Jr., P. A. Schuyler, S. J. Olson, C. L. Arteaga, and D. L. Page Transforming Growth Factor-{beta} and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia J Natl Cancer Inst, December 15, 1999; 91(24): 2096 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gertig, I. E. Stillman, C. Byrne, D. Spiegelman, S. J. Schnitt, J. L. Connolly, G. A. Colditz, and D. J. Hunter Association of Age and Reproductive Factors with Benign Breast Tissue Composition Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 873 - 879. [Abstract] [Full Text] |
||||
![]() |
T. W. Jacobs, C. Byrne, G. Colditz, J. L. Connolly, and S. J. Schnitt Radial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast Cancer N. Engl. J. Med., February 11, 1999; 340(6): 430 - 436. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |